BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 50.22
-0.08 (-0.16%)
Feb 4, 2026, 2:45 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 1.04B CNY in the quarter ending September 30, 2025, with 9.19% growth. This brings the company's revenue in the last twelve months to 3.71B, down -7.87% year-over-year. In the year 2024, BGI Genomics had annual revenue of 3.87B, down -11.10%.
Revenue (ttm)
3.71B
Revenue Growth
-7.87%
P/S Ratio
5.20
Revenue / Employee
1.00M
Employees
3,702
Market Cap
19.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | 8.40B | 5.60B | 199.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Hangzhou Tigermed Consulting | 6.56B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Joinn Laboratories(China)Co.,Ltd. | 1.67B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Amoy Diagnostics | 1.13B |